Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ powered by Logo_powered_by_socialpicks
1 point   posted on 02/13/08
Arrow_up
Arrow_down
Blog_photo
-9.70%
 risk: low

Pressure Biosciences, Inc. (PBIO) Up Almost 8% after Increased interest from Investors Who Attended the Red Chip Conference


Pressure Biosciences, Inc. (PBIO) Up Almost 8% after Increased interest from Investors Who Attended the Red Chip Conference

At the Red Chip conference in Scottsdale, Arizona, Pressure Biosciences Inc. CEO Richard Schumacher spoke to investors along with 30 other companies. He discussed the unique opportunity that his company has. Mr. Schumacher started the company in his garage when it was then named ‘Biomedica.’ The company recently changed its name to Pressure Biosciences and focuses exclusively on Pressure Testing sciences. They also went from trading on the OTC exchange to the NASDAQ.

In the conference, he stated that Pressure technology, patented by them, has a number of uses including Inactivation of Pathogens, Food Safety, Immunologistics, Protein Purification, Control of Chemical Reactions and Genomic/Proteometic Sample Preparation.

The market for its initial products is huge. Mr. Schumacher stated that there are over 390,000 researchers in 80,000 labs. The company has set a goal to capture 5% of this market share or about 4000 instruments in the next 5 years. They intend to do this through their recently enlarged sales staff that is experienced in the medical product sales field.

He also commented on the strong financial position the company is in. The current Book Value is $3.78 and the company trades at $5.64 a share. In two years, the company has gone from Idea to commercialization. They also have a number of well-publicized research breakthroughs giving their product excellent exposure. They offer investors an exceptional opportunity to get into a burgeoning Medical products industry with a breakthrough technology.

Please see disclaimer on QualityStocks.net website
  Related to:  
PBIO Pressure BioSciences Inc.


Comments (1)

Add Comment

Arrow_up
Arrow_down
Blog_photo
quality stocks   35%     1 point   commented 200 days ago reply

RedChip Covering of Pressure BioSciences Inc. (PBIO) Now Available for Online Viewing

Pressure BioSciences Inc.’s (Nasdaq:PBIO) February 2008 IPTV interview with RedChip Visibility is now available at http://www.visualwebcaster.com/Redchipfeb2008/. PressureBiosciences is one of 32 small-cap companies presented at RedChip Companies’ Small-Cap Investor Conference in Scottsdale, Ariz, earlier this month.

RedChip, an international small-cap research and financial public relations firm, covered companies in a wide range of sectors, such as technology, energy, consumer goods, healthcare, commodities, renewable energy and more.

The RedChip mission is to expose small-cap companies that meet specific criteria (effective management, mass appeal, growing sales, improving margins and profitability or near-term profitability) before they hit mainstream Wall Street. PressureBiosciences made the cut; the interview highlights the company’s products, business strategy, management and more.

PressureBiosciences is a life sciences company focused on the research, development, and commercialization of sample preparation systems. The company’s proprietary pressure cycling technology (PCT) uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions for genomic, poteomic and small molecule studies. PressureBiosciences holds 13 U.S. and 5 foreign patents covering multiple applications of PCT in the life sciences field to shed light on diseases.

Please see disclaimer on QualityStocks.net website

Your Comment




 
Pressure BioSciences Inc. (PBIO)
   SocialPicks Sentiment:    N/A

   This Quarter's Sentiment:
All:
20.0%
Top:
100.0%




TODAY'S TOP PICKS